YOLFTbeta
Avricore Health Inc

Avricore Health Inc

AVCR · V · Healthcare / Diagnostics & Research

0.045CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.045
Open0.04
Day Range0.04 – 0.045
52-Week Range0.045 – 0.10
Volume12.73K
Market Cap7.58M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.36
50-Day Avg0.0605
200-Day Avg0.0632

About

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Rodger Seccombe
  • Employees0
  • Headquarters700 ? 1199 West Hastings Street, Vancouver, BC, Canada, V6E 3T5, Canada
  • Websitehttps://avricore.com

Leadership

  • Mr. Rodger SeccombeCEO, CTO & Director · b. 1981
  • Ms. Kiriaki Smith CPA, CFO, CGACFO & Corporate Secretary · b. 1967
  • Mr. Will SeccombeCommunications Advisor

Financials

Income Statement

Currency: CAD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-3.58K4.93K111.36K239.27K223.59K256.24K249.04K282.26K1.46M305.59K83.36K--5.71K156.47K1.01M537.71K226.44K33.00K33.03K122.81K1.77M3.49M4.79M533.88K
Growth (%)--+37.83%+2157.51%+114.86%-6.56%+14.61%-2.81%+13.34%+417.14%-79.06%-72.72%---+2638.79%+547.86%-46.95%-57.89%-85.43%+0.09%+271.81%+1339.95%+97.08%+37.32%-88.84%
Cost of Revenue---122.84K150.07K142.38K165.92K157.23K224.69K1.25M255.89K---2.49K66.78K710.91K290.87K188.39K18.50K15.55K92.29K1.31M2.28M2.91M295.59K
Gross Profit-3.58K4.93K-11.48K89.20K81.21K90.32K91.81K57.57K209.25K49.70K83.36K--3.22K89.69K302.78K246.84K38.05K14.50K17.48K30.52K456.79K1.20M1.88M238.29K
Gross Margin-100.00%100.00%-10.31%37.28%36.32%35.25%36.86%20.40%14.34%16.26%100.00%--56.40%57.32%29.87%45.91%16.80%43.93%52.92%24.85%25.83%34.53%39.29%44.63%
Operating Expense-73.04K58.23K536.58K642.22K498.62K652.41K2.03M1.31M4.27M1.92M504.92K--1.73M2.45M2.64M2.23M2.92M1.61M876.63K1.78M1.27M1.89M1.74M1.50M
Operating Income-12.55K-69.46K-53.30K-548.06K-553.03K-417.41K-562.09K-1.94M-1.26M-4.06M-1.87M-421.56K-193.09K-774.63K-1.73M-2.36M-2.33M-1.99M-2.88M-1.60M-859.15K-1.75M-809.86K-687.25K139.35K-1.27M
Operating Margin--1940.71%-1080.52%-492.14%-231.13%-186.69%-219.36%-778.08%-445.39%-278.03%-612.77%-505.71%---30254.28%-1507.11%-230.20%-369.50%-1272.65%-4850.01%-2601.13%-1420.92%-45.80%-19.72%2.91%-237.21%
EBITDA-12.55K-68.94K-52.74K-354.68K-299.81K-446.51K-556.35K-1.93M-1.26M-4.06M-1.87M-384.25K-192.54K-770.29K-1.71M--2.04M-1.97M-2.35M-1.42M-859.15K-1.73M-626.81K-267.18K589.54K-1.13M
EBITDA Margin--1926.18%-1069.05%-318.49%-125.30%-199.70%-217.12%-772.98%-444.70%-277.86%-610.59%-460.94%---29990.20%--200.76%-366.92%-1036.16%-4303.13%-2601.13%-1406.28%-35.45%-7.67%12.32%-211.06%
Net Income-12.55K-69.59K-53.48K-731.48K-796.30K-378.30K-562.09K-1.94M-1.18M-3.99M-1.88M-306.56K283.43K-733.95K-2.20M-2.82M-2.61M-2.74M-4.14M-2.11M-1.17M-1.71M-818.23K-701.22K-668.98K-1.86M
Net Income Margin--1944.40%-1084.11%-656.84%-332.80%-169.20%-219.36%-778.08%-419.12%-273.53%-613.75%-367.76%---38520.01%-1802.12%-257.86%-508.95%-1826.85%-6380.63%-3554.24%-1390.90%-46.27%-20.12%-13.98%-348.16%
R&D---2.10K----189.56K223.26K76.52K31.89K10.16K34.73K56.14K90.44K208.78K242.30K251.51K-------
R&D as % of Total Revenue---1.89%----67.16%15.30%25.04%38.25%--982.72%57.80%20.60%45.06%111.07%-------
Interest Expense-132-2.06K1.69K1.57K2.71K2.34K2.02K4.19K6.66K13.74K1.14K2.63K1.06K002621025.14K158.95K38.44K5.42K0--
Interest Expense % of Total Revenue-3.69%-1.85%0.70%0.70%1.06%0.94%0.71%0.29%2.18%16.48%--18.57%0.00%0.00%0.05%0.05%15.59%481.24%31.30%0.31%0.00%--

Balance Sheet

Currency: CAD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets83.98K189.77K286.54K830.76K300.89K216.87K854.17K2.53M1.78M1.35M190.49K19.75K800.99K820.42K3.54M3.49M2.28M2.90M1.20M208.40K440.09K2.28M2.57M2.54M2.30M563.13K
Total Liabilities4.03K5.36K103.56K30.54K29.86K59.50K74.27K57.92K56.22K1.11M1.26M1.34M364.30K157.32K187.12K246.23K357.34K402.09K314.24K673.85K1.15M84.48K604.89K529.22K330.82K173.56K
Total Equity79.95K184.42K182.98K800.22K271.03K157.37K779.90K2.48M1.73M239.30K-1.07M-1.32M436.69K663.10K3.35M3.25M1.92M2.50M885.97K-465.45K-714.04K2.20M1.96M2.01M1.97M389.56K
Cash52.08K137.07K39.34K226.15K71.66K28.48K356.13K2.45M25.98K146.70K9.10K2.33K619.30K295.38K2.72M2.14M427.48K559.73K84.44K13.80K302.71K2.01M620.53K276.57K1.13M227.92K
Total Debt-------------------21.39K1.00M40.00K40.00K---
Net Debt-52.08K-137.07K-39.34K-226.15K-71.66K-28.48K-356.13K-2.45M-25.98K-146.70K-9.10K-2.33K-619.30K-295.38K-2.72M--427.48K-559.73K-84.44K7.59K698.85K-1.97M-580.53K---

Cash Flow

Currency: CAD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.48K-73.06K14.04K-755.46K-404.72K-314.66K-371.02K-876.72K-930.62K-3.61M-673.34K-58.66K-154.61K-539.52K-1.48M-1.93M-2.06M-1.77M-1.73M-686.41K-1.22M-1.23M-437.83K660.40K1.00M-789.93K
Investing Cash Flow----------------30.85K-6.34K-132.55K-155.00K-140.36K-140.36K-140.36K----
Financing Cash Flow62.56K185.65K75.65K1.02M250.87K263.49K742.92K3.02M96.00K2.15M535.73K51.90K771.57K247.46K3.94M3.36M362.00K2.03M1.40M615.76K1.51M3.08M253.88K42.50K56.60K0
Capital Expenditure02.60K30626.62K642044.25K56.96K8392.62K00031.86K30.85K30.85K6.34K3.78K55.00K105.36K105.36K140.36K1.20M1.05M205.35K114.36K
Free Cash Flow-10.48K-75.66K13.74K-782.08K-405.36K-314.66K-415.27K-933.68K-931.46K-3.61M-673.34K-58.66K-154.61K-571.38K-1.52M--2.07M-1.77M-1.78M-686.41K-1.22M-1.37M-1.64M-386.46K799.27K-904.29K
Dividends Paid---------------------0----
FCF to OCF100.00%103.56%97.82%103.52%100.16%100.00%111.93%106.50%100.09%100.07%100.00%100.00%100.00%105.91%102.08%-100.31%100.21%103.19%100.00%100.00%111.37%373.74%-58.52%79.56%114.48%
Dividend Paid to FCF---------------------0.00%----

Earnings

Report DateSep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Feb 15, 2008Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Aug 29, 2022Nov 29, 2022Dec 31, 2022May 2, 2023Dec 1, 2026
EPS Estimate-------------------------------------------------------------------------
EPS Actual-0.44-0.47-0.40-1.09-0.14-0.34-0.24-0.15-0.20-0.16-0.15-0.50-0.21-0.58-0.28-0.87-0.23-0.23-0.18-0.33-0.52-0.26-1.22-0.91-0.23-0.21-0.17-0.61-0.12-0.040.03-0.070.48-0.01-0.01-0.11-0.03-0.02-0.04-0.03-0.02-0.05-0.04-0.10-0.05-0.04-0.02-0.07-0.05-0.03-0.03-0.04-0.02-0.03-0.02-0.05-0.01-0.01-0.01-0.00-0.00-0.00-0.01-0.01-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-
Surprise-------------------------------------------------------------------------
Timing-------------Pre-market------------------------------------------------------Pre-marketPre-market-Pre-marketAfter-hours

Key Statistics & Ratios

Market Cap7.58M
Enterprise Value6.66M
Trailing P/E0.00
Forward P/E0.00
Price / Sales39.28
Price / Book6.83
EPS-0.01
Book Value0.009
Revenue (TTM)193.04K
Gross Profit (TTM)-69.30K
EBITDA-1.10M
Profit Margin0.00%
Operating Margin-292.01%
Return on Equity-132.03%
Return on Assets-50.37%
Shares Outstanding126.37M
Shares Float114.66M
Beta0.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Nov 21, 20161:4